129 related articles for article (PubMed ID: 11422411)
21. Thrombocytosis--report of a case.
Thomas M; Pavithran K; Salil ; Somarajan A
J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
[TBL] [Abstract][Full Text] [Related]
22. A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Anger B; Porzsolt F; Leichtle R; Heinze B; Bartram C; Heimpel H
Blut; 1989 Jun; 58(6):275-8. PubMed ID: 2736308
[TBL] [Abstract][Full Text] [Related]
23. Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders.
Fruchtman SM; Petitt RM; Gilbert HS; Fiddler G; Lyne A;
Leuk Res; 2005 May; 29(5):481-91. PubMed ID: 15755500
[TBL] [Abstract][Full Text] [Related]
24. Transition of polycythemia vera to chronic myeloid leukaemia.
Saviola A; Fiorani C; Ferrara L; Mazzocchi V; Zucchini P; Temperani P; Longo G; Emilia G; Torelli G
Eur J Haematol; 2005 Sep; 75(3):264-6. PubMed ID: 16104886
[TBL] [Abstract][Full Text] [Related]
25. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
Tripathi AK; Ahmad R; Sawlani KK
J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
[TBL] [Abstract][Full Text] [Related]
26. Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
Alvarez-Larrán A; Martínez-Avilés L; Hernández-Boluda JC; Ferrer-Marín F; Antelo ML; Burgaleta C; Mata MI; Xicoy B; Martínez-Trillos A; Gómez-Casares MT; Durán MA; Marcote B; Ancochea A; Senín A; Angona A; Gómez M; Vicente V; Cervantes F; Bellosillo B; Besses C
Ann Hematol; 2014 Dec; 93(12):2037-43. PubMed ID: 24981691
[TBL] [Abstract][Full Text] [Related]
27. Progress with interferon in CML--results of the MRC UK CML III study.
Shepherd PC; Richards SM; Allan NC
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S15-8. PubMed ID: 8769693
[TBL] [Abstract][Full Text] [Related]
28. Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.
Baird JH; Minniti CP; Lee JM; Tian X; Wu C; Jackson M; Alam S; Taylor JG; Kato GJ
Br J Haematol; 2015 Mar; 168(5):737-46. PubMed ID: 25377027
[TBL] [Abstract][Full Text] [Related]
29. Hydroxyurea induced perimalleolar ulcers.
Saravu K; Velappan P; Lakshmi N; Shastry BA; Thomas J
J Korean Med Sci; 2006 Feb; 21(1):177-9. PubMed ID: 16479088
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR;
N Engl J Med; 2005 Jul; 353(1):33-45. PubMed ID: 16000354
[TBL] [Abstract][Full Text] [Related]
31. Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Oberg G;
Hematol J; 2004; 5(6):462-6. PubMed ID: 15570285
[TBL] [Abstract][Full Text] [Related]
32. Transition of polycythemia vera to chronic neutrophilic leukemia.
Higuchi T; Oba R; Endo M; Harada H; Mori H; Niikura H; Omine M; Fujita K
Leuk Lymphoma; 1999 Mar; 33(1-2):203-6. PubMed ID: 10194140
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyurea in the treatment of polycythemia vera: a prospective study of 100 patients over a 20-year period.
West WO
South Med J; 1987 Mar; 80(3):323-7. PubMed ID: 3824016
[TBL] [Abstract][Full Text] [Related]
34. Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
Shepherd PC; Richards S; Allan NC
Br J Haematol; 1994 Jan; 86(1):92-6. PubMed ID: 8011552
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
Jehn U; Pötscher C; Heinemann V
Leuk Lymphoma; 1995 Sep; 19(1-2):153-7. PubMed ID: 8574162
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
37. Modern treatment strategies in polycythemia vera.
Gilbert HS
Semin Hematol; 2003 Jan; 40(1 Suppl 1):26-9. PubMed ID: 12682879
[TBL] [Abstract][Full Text] [Related]
38. Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.
Tefferi A; Elliott MA; Kao PC; Yoon S; El-Hemaidi I; Pearson TC
Blood; 2000 Aug; 96(4):1582-4. PubMed ID: 10942409
[TBL] [Abstract][Full Text] [Related]
39. Serum vitamin E levels in patients of chronic myeloid leukaemia.
Ghalaut PS; Singh V; Gupta S
J Assoc Physicians India; 1999 Jul; 47(7):703-4. PubMed ID: 10778591
[TBL] [Abstract][Full Text] [Related]
40. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
